Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The VOICE-COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04508972
Recruitment Status : Recruiting
First Posted : August 11, 2020
Last Update Posted : September 28, 2020
Sponsor:
Collaborators:
Amazon Web Services (AWS) Canada
University of California
Information provided by (Responsible Party):
Abhinav Sharma, McGill University Health Centre/Research Institute of the McGill University Health Centre

Brief Summary:
The VOICE-COVID study will evaluate the concordance of screening for symptoms of COVID-19 using a voice based device (Amazon Alexa) compared to manual screening by a study coordinator for individuals entering the Cardiology/Heart Failure clinic at the McGill University Health Centre.

Condition or disease Intervention/treatment
Covid19 Device: Alexa Amazon

Detailed Description:

This study is an open-label, non-interventional, prospective study.

All individuals entering the Heart Failure (HF) Clinic of the McGill University Health Center will be asked to participate. A poster with instructions to ask the participants (employees or patients) to speak with the Amazon Alexa device. The participant will remain 6 feet away from the device. The Amazon Alexa will ask the survey questions. A study coordinator will then ask the same questions along with some additional questions about Amazon Alexa usability. We will study the correlation between the Alexa response and the response to the study coordinator using K-squared statistic tests.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Voice-based Identification of Clinical Features Requiring Emergent Action in Patients With Suspected COVID-19 Infection (VOICE-COVID) Study
Actual Study Start Date : July 1, 2020
Estimated Primary Completion Date : October 1, 2020
Estimated Study Completion Date : November 1, 2020

Intervention Details:
  • Device: Alexa Amazon
    To test the use of the Amazon Alexa device as a tool to conduct screening of employees and patients at the point of entry into the Heart Failure (HF) Clinic of the McGill University Health Center.


Primary Outcome Measures :
  1. Correlation between data captured using Amazon Alexa compared to manual (human) collected data. [ Time Frame: Day 1 ]
    Determine the ability of the Amazon Alexa device to properly capture answers from participants and correlate with the answers retrieved by the study coordinator, we will use a linear regression approach to model the relationship between both surveys



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Any employees or patients entering the Heart Failure clinic at the McGill University Health Center
Criteria

Inclusion Criteria:

  • Adults >=18 yrs who is entering the HF clinic
  • Speaks either English or French

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04508972


Contacts
Layout table for location contacts
Contact: Abhinav Sharma, MD 514 934-1934 abhinav.sharma@mcgill.ca
Contact: Julie Lebel 514 934-1934 ext 38106 julie.lebel@muhc.mcgill.ca

Locations
Layout table for location information
Canada, Quebec
Muhc-Rimuhc Recruiting
Montreal, Quebec, Canada, H4A 3J1
Contact: Abhinav h Sharma, MD    514 934-1934    abhinav.sharma@mcgill.ca   
Contact: Julie Lebel    514 934-1934 ext Sharma    abhinav.sharma@mcgill.ca   
Principal Investigator: Abhinav Sharma, MD         
Sponsors and Collaborators
McGill University Health Centre/Research Institute of the McGill University Health Centre
Amazon Web Services (AWS) Canada
University of California
Investigators
Layout table for investigator information
Principal Investigator: Abhinav Sharma, MD McGill University Health Centre/Research Institute of the McGill University Health Centre
Layout table for additonal information
Responsible Party: Abhinav Sharma, Cardiologist, McGill University Health Centre/Research Institute of the McGill University Health Centre
ClinicalTrials.gov Identifier: NCT04508972    
Other Study ID Numbers: 2020-6583
First Posted: August 11, 2020    Key Record Dates
Last Update Posted: September 28, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: We aim to disseminate these results through publications in peer review journals and submission to conferences. Currently, many conferences are converting into a virtual format which would enable our results to be disseminated over a wide audience.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Abhinav Sharma, McGill University Health Centre/Research Institute of the McGill University Health Centre:
COVID-19
Alexa Device
Voice-based technologies
Screening
Safety